Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AbbVie Inc (NYSE:ABBV)

61.38
Delayed Data
As of 4:01pm ET
 -0.28 / -0.45%
Today’s Change
51.60
Today|||52-Week Range
68.12
-1.98%
Year-to-Date
Boehringer Ingelheim's Humira Biosimilar Under Review by EMA, FDA
3:51pm / GuruFocus News - Paid Partner Content
How Johnson & Johnson Beat Every Other Big Pharma Stock in 2016
9:11am / MotleyFool.com - Paid Partner Content
McKesson (MCK) Q3 Earnings: Stock Likely to Disappoint?
10:52am / Zacks.com - Paid Partner Content
Allergan's Uterine Fibroids Candidate Positive in Phase III
Jan 18 / Zacks.com - Paid Partner Content
Vertex Pharma (VRTX) Q4 Earnings: Stock Likely to Beat?
9:21am / Zacks.com - Paid Partner Content
5 Most Important Drugs to Johnson & Johnson in 2017
Jan 18 / MotleyFool.com - Paid Partner Content
Bristol-Myers (BMY) Q4 Earnings: Will the Stock Disappoint?
9:21am / Zacks.com - Paid Partner Content
What???s Ahead for Johnson & Johnson (JNJ) in Q4 Earnings?
Jan 18 / Zacks.com - Paid Partner Content
Biogen (BIIB) Q4 Earnings: What's in Store for the Stock?
9:21am / Zacks.com - Paid Partner Content
Biotech Sector to See M&A, Earnings Action
Jan 17 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close61.66
Today’s open61.45
Day’s range61.12 - 61.88
Volume5,342,357
Average volume (3 months)7,483,673
Market cap$100.2B
Dividend yield4.17%
Data as of 4:01pm ET, 01/19/2017

Growth & Valuation

Earnings growth (last year)+184.55%
Earnings growth (this year)+12.41%
Earnings growth (next 5 years)+15.81%
Revenue growth (last year)+14.52%
P/E ratio16.6
Price/Sales4.24
Price/Book25.16

Competitors

 Today’s
change
Today’s
% change
SNYSanofi-0.59-1.45%
GSKGlaxoSmithKline-0.14-0.36%
BMYBristol-Myers Squibb-0.58-1.03%
CELGCelgene-1.60-1.39%
Data as of 4:02pm ET, 01/19/2017

Financials

Next reporting dateJanuary 27, 2017
EPS forecast (this quarter)$1.19
Annual revenue (last year)$22.9B
Annual profit (last year)$5.1B
Net profit margin22.39%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Richard A. Gonzalez
Senior Vice President-
Operations
Azita Saleki-Gerhardt
Corporate headquarters
North Chicago, Illinois

Forecasts


Search for Jobs